Balyasny Asset Management’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-13,600
Closed -$1.12M 3116
2025
Q4
$1.12M Buy
13,600
+6,100
+81% +$475K ﹤0.01% 2138
2025
Q3
$563K Buy
+7,500
New +$559K ﹤0.01% 2346
2025
Q1
Sell
-8,400
Closed -$657K 2960
2024
Q4
$657K Buy
+8,400
New +$714K ﹤0.01% 2097
2024
Q1
Sell
-14,100
Closed -$1.09M 2795
2023
Q4
$1.09M Buy
+14,100
New +$987K ﹤0.01% 1649

Other funds holding GEHC

Balyasny Asset Management's GEHC Position: Q1 2026 in Review

Balyasny Asset Management reduced its GE HealthCare (GEHC) stake by 64% in Q1 2026, selling an estimated $973K and leaving 6,802 shares worth $484K. The position accounts for ﹤0.01% of the portfolio, ranked #2383.

Balyasny Asset Management first reported a position in GEHC in Q1 2023 and has held it in 6 quarters since. The position peaked at $58.4M in Q2 2025. 1,264 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

  • Balyasny Asset Management held 6,802 shares of GE HealthCare worth $484K as of Q1 2026.
  • Balyasny Asset Management sold 12,342 GE HealthCare shares in Q1 2026, an estimated $973K.
  • GE HealthCare made up ﹤0.01% of Balyasny Asset Management's portfolio in Q1 2026, its #2383 holding.
  • Balyasny Asset Management first reported a position in GE HealthCare in Q1 2023 and has held it in 6 quarters since.
  • Balyasny Asset Management's GE HealthCare position peaked at $58.4M in Q2 2025.
  • 1,264 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.